A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis

Hormone and Metabolic Research

Volumn 42, Issue 12, 2010, Pages 854-859

  Auinger, A ^a   Valenti, L ^b   Pfeuffer, M ^a   Helwig, U ^c   Herrmann, J ^a   Fracanzani, A L ^b   Dongiovanni, P ^b   Fargion, S ^b   Schrezenmeir, J ^a   Rubin, D ^c  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

FATP5; genetic variation; hepatic steatosis; postprandial insulin resistance

Indexed keywords

ALANINE AMINOTRANSFERASE; FATTY ACID TRANSPORTER; FATTY ACID TRANSPORTER 5; INSULIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; BODY MASS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME ACTIVITY; GENOTYPE; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PROTEIN VARIANT; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACID TRANSPORT PROTEINS; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ORGAN SPECIFICITY; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES;

EID: 78649331070     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1267186     Document Type: Article

References (30)

1. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005 42 44-52
2. Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver Fat in the Metabolic Syndrome. J Clin Endocrinol Metab 2007 92 3490-3497
3. Seppala-Lindroos A, Vehkavaara S, Hakkinen A-M, Goto T, Westerbacka J, Sovijarvi A, Halavaara J, Yki-Jarvinen H. Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men. J Clin Endocrinol Metab 2002 87 3023-3028
4. Gimeno RE. Fatty acid transport proteins. Curr Opin Lipidol 2007 18 271-276
5. Hirsch D, Stahl A, Lodish HF. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA 1998 95 8625-8629
6. Steinberg SJ, Mihalik SJ, Kim DG, Cuebas DA, Watkins PA. The human liver-specific homolog of very long-chain acyl-CoA synthetase is cholate: CoA ligase. J Biol Chem 2000 275 15605-15608
7. Hubbard B, Doege H, Punreddy S, Wu H, Huang X, Kaushik VK, Mozell RL, Byrnes JJ, Stricker-Krongrad A, Chou CJ, Tartaglia LA, Lodish HF, Stahl A, Gimeno RE. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity. Gastroenterology 2006 130 1259-1269
8. Doege H, Grimm D, Falcon A, Tsang B, Storm TA, Xu H, Ortegon AM, Kazantzis M, Kay MA, Stahl A. Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia. J Biol Chem 2008 283 22186-22192
9. Doege H, Baillie RA, Ortegon AM, Tsang B, Wu Q, Punreddy S, Hirsch D, Watson N, Gimeno RE, Stahl A. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology 2006 130 1245-1258
10. Fisher E, Nitz I, Lindner I, Rubin D, Boeing H, Mohlig M, Hampe J, Schreiber S, Schrezenmeir J, Doring F. Candidate gene association study of type 2 diabetes in a nested case-control study of the EPIC-Potsdam cohort role of fat assimilation.Mol nutr Food Res 2007;51:185191.
11. Rubin D, Helwig U, Nothnagel M, Folsch U, Schreiber S, Schrezenmeir J. Association of postprandial and fasting triglycerides with traits of the metabolic syndrome in the Metabolic Intervention Cohort Kiel (MICK). Eur J Endocrinol 2010 162 719-727
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419
13. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test. Diabetes Care 2001 24 539-548
14. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 2001 96 2448-2455
15. Caballeria L, Pera G, Auladell MA, Toran P, Munoz L, Miranda D, Aluma A, Casas JD, Sanchez C, Gil D, Auba J, Tibau A, Canut S, Bernad J, Aizpurua MM. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol 2010 22 24-32
16. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005 41 1313-1321
17. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, Lynch NJ, MacPherson AJ, Bridger S, van Deventer S, Stokkers P, Morin P, Mirza MM, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999 65 1647-1655 (Pubitemid 30468677)
18. Wingender E, Dietze P, Karas H, Knuppel R. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucl Acids Res 1996 24 238-241
19. Merika M, Orkin SH. DNA-binding specificity of GATA family transcription factors. Mol Cell Biol 1993 13 3999-4010
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 21 263-265
21. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucl Acids Res 2001 29 308-311
22. Goto T, Onuma T, Takebe K, Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995 19 841-845
23. Sasaki S, Masaki N, Yashiro H, Kudo M, Kimura K, Takebe K. Degradation of insulin in perfused liver and skeletal muscle and insulin secretion in perfused pancreas of liver injury rat. Horm Metab Res 1981 13 561-564
24. Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 2007 293 E1663-E1669
25. Schwarz J-M, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 2003 77 43-50
26. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Häkkinen A, Olofsson SO, Yki-Järvinen H. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006 49 755-765
27. Pedrini MT, Kranebitter M, Niederwanger A, Kaser S, Engl J, Debbage P, Huber LA, Patsch JR. Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels. Diabetologia 2005 48 756-766
28. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005 115 1343-1351
29. Rijkelijkhuizen JM, Doesburg T, Girman CJ, Mari A, Rhodes T, Gastaldelli A, Nijpels G, Dekker JM. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response. Metabolism 2009 58 196-203
30. Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, Häkkinen AM, Fredriksson J, Yki-Järvinen H. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004 47 1360-1369